AML IP v. Walgreen Co. — Dismissed With Prejudice in 18 Days
AML IP, LLC asserted US7177838B1 — a patent covering methods and apparatus for conducting electronic commerce transactions using electronic tokens — against Walgreen Co. in the Eastern District of Texas. The plaintiff voluntarily dismissed with prejudice before the defendant filed any response, closing the case in just 18 days.
E-commerce token patent suit ends before defendant responds
On November 4, 2024, AML IP, LLC filed a patent infringement action against Walgreen Co. in the Eastern District of Texas (Case No. 2:24-cv-00899), presided over by Judge Rodney Gilstrap. The complaint asserted US7177838B1, which covers a method and apparatus for conducting electronic commerce transactions using electronic tokens — a foundational claim in the digital payments and retail e-commerce space. Walgreens, as a major retail chain with a significant digital commerce footprint, was a commercially prominent target for this assertion.
The case closed just 18 days after filing. AML IP filed a Notice of Voluntary Dismissal under Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, dismissing all claims against Walgreen Co. with prejudice. Because Walgreen Co. had not yet answered the complaint or moved for summary judgment, the dismissal was effective immediately upon filing. Judge Gilstrap accepted and acknowledged the dismissal, directed the clerk to close the case, and ordered each party to bear its own costs and attorneys’ fees. All pending relief was denied as moot.
The 18-day lifespan is notably brief even by NPE litigation standards, where early voluntary dismissals are not uncommon. The ‘with prejudice’ designation is significant: it bars AML IP from reasserting the same claims against Walgreen Co. again. The public record does not disclose whether a private settlement was reached, whether Walgreens communicated a credible invalidity or non-infringement position pre-answer, or whether AML IP chose to prioritise other defendants. The absence of any fee award suggests neither party sought sanctions.
Filing to Voluntary dismissal in 18 days
18 days — well below the median district court patent case duration, suggesting early resolution
Dismissed with prejudice: what the voluntary exit means for both parties
Rule 41(a)(1)(A)(i) dismissal: plaintiff exits before answer
Under Rule 41(a)(1)(A)(i), a plaintiff may dismiss without a court order if the defendant has not yet answered or moved for summary judgment. Here, AML IP invoked this right but elected dismissal with prejudice — a stricter outcome than the rule requires. The court formally accepted and acknowledged the dismissal, making it a final judicial act. This forecloses any future assertion of the same claims by AML IP against Walgreen Co.
Permanent bar on re-filingWith prejudice: a permanent concession by AML IP
A voluntary dismissal with prejudice operates as a final adjudication on the merits, permanently extinguishing AML IP’s right to reassert US7177838B1 against Walgreen Co. This is a meaningfully stronger outcome for Walgreens than a dismissal without prejudice, which would leave the door open for re-filing. The public record does not disclose whether a confidential settlement accompanied this concession, but the with-prejudice designation itself represents a lasting benefit to Walgreen Co. regardless.
Merits-equivalent finalityAML IP closes one front — patent remains live for others
While AML IP surrendered its position against Walgreen Co. permanently, US7177838B1 itself is not invalidated by this dismissal. The patent survives and AML IP retains the right to assert it against other parties. The speed of exit — before any substantive engagement — suggests this defendant was strategically deprioritised or a resolution was reached that made continued litigation unnecessary. AML IP’s broader assertion programme is unaffected.
Patent survives for third partiesCost-neutral exit: no fee exposure for either side
The court’s order that each party bears its own costs and attorneys’ fees removes any financial sting for both sides. For Walgreens, this represents an efficient resolution with no judicial fee exposure and a permanent bar against re-suit. For AML IP, exiting before incurring substantial litigation costs preserves resources for other assertion targets. Companies in the retail e-commerce and digital payments sectors facing similar claims from AML IP should note the patent remains enforceable.
No fee award enteredFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | AML IP, LLC | Company | Non-practising entity (NPE) — holder of US7177838B1 covering e-commerce token transactionsSearch in Eureka ↗ |
| Defendant | Walgreen, Co. | Company | Walgreen Co. — major US retail pharmacy chain with significant digital commerce operationsSearch in Eureka ↗ |
| Plaintiff counsel | William P. Ramey , III | Attorney | Counsel for AML IP, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Ramey LLP | Law Firm | Representing AML IP, LLCSearch in Eureka ↗ |
| Presiding judge | Judge Rodney Gilstrap | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The court’s order accepts and acknowledges a plaintiff-initiated Rule 41(a)(1)(A)(i) dismissal with prejudice. The ‘with prejudice’ designation elevates this beyond a routine procedural exit — it constitutes a final adjudication on the merits, permanently barring AML IP from reasserting the same claims against Walgreen Co. The order’s cost-neutrality clause, directing each party to bear its own fees, suggests no exceptional circumstances finding and no fee-shifting motion was pursued. The denial of all pending relief as moot closes the docket cleanly with no residual claims.
US7177838B1 — Electronic commerce transactions using electronic tokens
US7177838B1 (application number US09/553695) is a utility patent protecting a method and apparatus for conducting electronic commerce transactions using electronic tokens. The patent sits at the intersection of digital payments infrastructure and e-commerce transaction processing — a domain that encompasses tokenised checkout, digital wallet operations, and loyalty-based payment systems. Its granted status as a B1 publication indicates it issued without post-grant amendment, suggesting the claims as granted reflect the original prosecution scope.
The commercial relevance of this patent is significant in an era where tokenised payment flows underpin billions of retail transactions annually. Any major retailer operating a digital commerce platform, mobile wallet, or token-based loyalty system is a plausible infringement target under a broad reading of the claims. AML IP’s willingness to assert this patent against a defendant of Walgreens’ scale — one of the largest US retail pharmacy chains — signals confidence in the patent’s enforceability. The patent’s survival after this dismissal means it remains a live competitive risk for the broader retail and payments sector.
Should you run an FTO analysis against US7177838B1?
Any company developing or operating electronic token-based transaction systems — including digital wallets, tokenised checkout flows, retail loyalty platforms, or stored-value card systems — should treat US7177838B1 as a material FTO risk. AML IP has demonstrated willingness to assert this patent against major retail operators, and the patent’s continued validity after this dismissal means enforcement exposure persists. This is particularly relevant for companies operating in or entering the US market with consumer-facing digital payment products.
PatSnap Eureka’s FTO Search Agent can map US7177838B1’s claim scope against your product architecture, surface relevant prior art that may support invalidity arguments, and identify any continuation or related family members that could extend the assertion risk. Eureka also enables monitoring of AML IP’s filing activity and Ramey LLP’s docket across the Eastern District of Texas, providing early warning of new assertions in this technology domain before they reach your organisation.
Run a freedom-to-operate analysis on US7177838B1 to assess your product’s exposure
Run FTO in Eureka →Similar electronic commerce token patent cases in US district courts
Explore related NPE patent infringement actions asserting electronic commerce and digital token transaction patents in the Eastern District of Texas and comparable US venues.
What this case signals for the e-commerce and retail IP landscape
An 18-day NPE suit ending in with-prejudice dismissal carries distinct signals for digital commerce patent risk management.
With-prejudice exits are rare NPE concessions — note them
Most NPE voluntary dismissals are without prejudice, preserving the option to re-file. AML IP’s with-prejudice dismissal against Walgreen Co. is an unusually strong concession. Companies receiving demand letters or early complaints from AML IP over US7177838B1 should consider whether a similar resolution is achievable before substantive motion practice begins.
US7177838B1 remains active — FTO review warranted for e-commerce players
The dismissal does not touch the validity or scope of US7177838B1. Any company operating electronic token-based transaction systems — including digital wallets, loyalty point systems, or tokenised checkout flows — should treat this patent as an active risk. An FTO analysis is advisable before launching or scaling relevant products, particularly given Judge Gilstrap’s Eastern District of Texas docket.
AML v Walgreen — key questions answered
AML IP, LLC filed a patent infringement complaint against Walgreen Co. on November 4, 2024 in the Eastern District of Texas, asserting US7177838B1. The plaintiff voluntarily dismissed all claims with prejudice under Rule 41(a)(1)(A)(i) on November 22, 2024 — just 18 days after filing — before Walgreens answered or moved for summary judgment. Each party was ordered to bear its own costs.
Dismissal with prejudice operates as a final adjudication on the merits. AML IP is permanently barred from reasserting the same patent claims — US7177838B1 — against Walgreen Co. in future litigation. This is a stronger outcome for Walgreens than a without-prejudice dismissal, which would have left the door open for re-filing.
No. The voluntary dismissal with prejudice applies only to AML IP’s claims against Walgreen Co. specifically. The patent US7177838B1 remains in force and AML IP retains the right to assert it against other defendants. Companies operating electronic token-based transaction systems should continue to treat this patent as an active enforcement risk.
AML IP, LLC is a non-practising entity (NPE) that holds US7177838B1, a patent covering electronic commerce transactions using electronic tokens. The company is represented by William P. Ramey III of Ramey LLP, a prolific NPE litigation firm in the Eastern District of Texas. The rapid with-prejudice dismissal against Walgreens is consistent with a multi-defendant assertion strategy where individual defendants are resolved quietly.
The Eastern District of Texas, particularly before Judge Rodney Gilstrap, remains a favoured venue for patent assertion entities due to its historically plaintiff-friendly procedural environment and established patent litigation infrastructure. Ramey LLP regularly files in this district. The choice of venue is a common strategic consideration for NPEs seeking efficient case management and favourable discovery timelines.
PatSnap Eureka searches patents and litigation data to answer instantly.